Header Logo

Connection

Elizabeth Evans to Middle Aged

Back to Details
This is a "connection" page, showing publications Elizabeth Evans has written about Middle Aged.
Elizabeth Evans
Connection Strength
0.919
Middle Aged
  1. Stopka TJ, Rottapel R, Friedmann PD, Pivovarova E, Evans EA. Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study. Addict Sci Clin Pract. 2024 Sep 12; 19(1):68.
    View in: PubMed
    Score: 0.068
  2. Evans E, Jacobs M. Diabetes and Financial Well-Being: Differential Hardship Among Vulnerable Populations. Sci Diabetes Self Manag Care. 2024 08; 50(4):263-274.
    View in: PubMed
    Score: 0.067
  3. Bailey A, Evans EA. Holyoke Early Access to Recovery and Treatment (HEART): A case study of a court-based intervention to reduce opioid overdose. J Ethn Subst Abuse. 2024 Oct-Dec; 23(4):1039-1061.
    View in: PubMed
    Score: 0.061
  4. Evans EA, Harrington C, Roose R, Lemere S, Buchanan D. Perceived Benefits and Harms of Involuntary Civil Commitment for Opioid Use Disorder. J Law Med Ethics. 2020 12; 48(4):718-734.
    View in: PubMed
    Score: 0.052
  5. Evans EA, Goff SL, Upchurch DM, Grella CE. Childhood adversity and mental health comorbidity in men and women with opioid use disorders. Addict Behav. 2020 03; 102:106149.
    View in: PubMed
    Score: 0.048
  6. Evans EA, Yoo C, Huang D, Saxon AJ, Hser YI. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2?years: Results from a multisite randomized trial of adults with opioid use disorder. J Subst Abuse Treat. 2019 11; 106:19-28.
    View in: PubMed
    Score: 0.048
  7. Evans EA, Zhu Y, Yoo C, Huang D, Hser YI. Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder. Addiction. 2019 08; 114(8):1396-1404.
    View in: PubMed
    Score: 0.047
  8. Evans EA, Glover DL, Washington DL, Hamilton AB. Psychosocial Factors that Shape Substance Abuse and Related Mental Health of Women Military Veterans who Use Community-Based Services. Subst Use Misuse. 2018 09 19; 53(11):1878-1892.
    View in: PubMed
    Score: 0.043
  9. Evans EA, Upchurch DM, Simpson T, Hamilton AB, Hoggatt KJ. Differences by Veteran/civilian status and gender in associations between childhood adversity and alcohol and drug use disorders. Soc Psychiatry Psychiatr Epidemiol. 2018 04; 53(4):421-435.
    View in: PubMed
    Score: 0.042
  10. Evans EA, Grella CE, Washington DL, Upchurch DM. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. Drug Alcohol Depend. 2017 05 01; 174:128-136.
    View in: PubMed
    Score: 0.040
  11. Evans EA, Grella CE, Upchurch DM. Gender differences in the effects of childhood adversity on alcohol, drug, and polysubstance-related disorders. Soc Psychiatry Psychiatr Epidemiol. 2017 07; 52(7):901-912.
    View in: PubMed
    Score: 0.040
  12. Evans E, Padwa H, Li L, Lin V, Hser YI. Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment. J Subst Abuse Treat. 2015 Dec; 59:10-9.
    View in: PubMed
    Score: 0.036
  13. Evans E, Jaffe A, Urada D, Anglin MD. Differential outcomes of court-supervised substance abuse treatment among California parolees and probationers. Int J Offender Ther Comp Criminol. 2012 Jun; 56(4):539-56.
    View in: PubMed
    Score: 0.027
  14. Evans E, Anglin MD, Urada D, Yang J. Promising practices for delivery of court-supervised substance abuse treatment: perspectives from six high-performing California counties operating Proposition 36. Eval Program Plann. 2011 May; 34(2):124-34.
    View in: PubMed
    Score: 0.026
  15. Evans E, Hser YI, Huang D. Employment services utilization and outcomes among substance abusing offenders participating in California's proposition 36 drug treatment initiative. J Behav Health Serv Res. 2010 Oct; 37(4):461-76.
    View in: PubMed
    Score: 0.024
  16. Evans E, Li L, Hser YI. Treatment entry barriers among California's Proposition 36 offenders. J Subst Abuse Treat. 2008 Dec; 35(4):410-8.
    View in: PubMed
    Score: 0.022
  17. Evans E, Longshore D, Prendergast M, Urada D. Evaluation of the Substance Abuse and Crime Prevention Act: client characteristics, treatment completion and re-offending three years after implementation. J Psychoactive Drugs. 2006 Nov; Suppl 3:357-67.
    View in: PubMed
    Score: 0.020
  18. Michener PS, Bianchet E, Fox S, Evans EA, Friedmann PD. "Expected to happen": perspectives on post-release overdose from recently incarcerated people with opioid use disorder. Harm Reduct J. 2024 07 22; 21(1):138.
    View in: PubMed
    Score: 0.017
  19. Jacobs MM, Evans E, Ellis C. Financial Well-Being Among US Adults with Vascular Conditions: Differential Impacts Among Blacks and Hispanics. Ethn Dis. 2024 Jan; 34(1):41-48.
    View in: PubMed
    Score: 0.017
  20. Jacobs M, Evans E, Ellis C. Exploring the association between social determinants and aphasia impairment: A retrospective data integration approach. PLoS One. 2024; 19(3):e0299979.
    View in: PubMed
    Score: 0.016
  21. Barnett A, Edwards K, Harper R, Evans E, Alexander D, Choudhary M, Richards G. The Association Between Autistic Traits and Disordered Eating is Moderated by Sex/Gender and Independent of Anxiety and Depression. J Autism Dev Disord. 2021 Jun; 51(6):1866-1879.
    View in: PubMed
    Score: 0.013
  22. Zhu Y, Evans EA, Mooney LJ, Saxon AJ, Kelleghan A, Yoo C, Hser YI. Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial. J Neuroimmune Pharmacol. 2018 12; 13(4):488-497.
    View in: PubMed
    Score: 0.011
  23. Wang L, Min JE, Krebs E, Evans E, Huang D, Liu L, Hser YI, Nosyk B. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. Int J Drug Policy. 2017 11; 49:32-40.
    View in: PubMed
    Score: 0.010
  24. Krebs E, Urada D, Evans E, Huang D, Hser YI, Nosyk B. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction. 2017 May; 112(5):838-851.
    View in: PubMed
    Score: 0.010
  25. Metz VE, Sullivan MA, Jones JD, Evans E, Luba R, Vogelman J, Comer SD. Racial Differences in HIV and HCV Risk Behaviors, Transmission, and Prevention Knowledge among Non-Treatment-Seeking Individuals with Opioid Use Disorder. J Psychoactive Drugs. 2017 Jan-Mar; 49(1):59-68.
    View in: PubMed
    Score: 0.010
  26. Iacono T, Evans E, Davis A, Bhardwaj A, Turner B, Torr J, Trollor JN. Family caring of older adults with intellectual disability and coping according to loci of responsibility. Res Dev Disabil. 2016 Oct; 57:170-80.
    View in: PubMed
    Score: 0.010
  27. Hser YI, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, Woody G, Liu D, Wakim P, Matthews AG, Hatch-Maillette M, Jelstrom E, Wiest K, McLaughlin P, Ling W. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction. 2016 Apr; 111(4):695-705.
    View in: PubMed
    Score: 0.009
  28. Fortenberry GZ, Beckman J, Schwartz A, Prado JB, Graham LS, Higgins S, Lackovic M, Mulay P, Bojes H, Waltz J, Mitchell Y, Leinenkugel K, Oriel MS, Evans E, Calvert GM. Magnitude and characteristics of acute paraquat- and diquat-related illnesses in the US: 1998-2013. Environ Res. 2016 Apr; 146:191-9.
    View in: PubMed
    Score: 0.009
  29. Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD, Wood E, Montaner JS. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs. Clin Infect Dis. 2015 Oct 01; 61(7):1157-65.
    View in: PubMed
    Score: 0.009
  30. Chitty KM, Evans E, Torr JJ, Iacono T, Brodaty H, Sachdev P, Trollor JN. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study. Aust N Z J Psychiatry. 2016 Apr; 50(4):352-62.
    View in: PubMed
    Score: 0.009
  31. Nosyk B, Li L, Evans E, Urada D, Huang D, Wood E, Rawson R, Hser YI. Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012. Drug Alcohol Depend. 2014 Oct 01; 143:149-57.
    View in: PubMed
    Score: 0.008
  32. Headley S, Germain M, Wood R, Joubert J, Milch C, Evans E, Poindexter A, Cornelius A, Brewer B, Pescatello LS, Parker B. Short-term aerobic exercise and vascular function in CKD stage 3: a randomized controlled trial. Am J Kidney Dis. 2014 Aug; 64(2):222-9.
    View in: PubMed
    Score: 0.008
  33. Nosyk B, Sun H, Evans E, Marsh DC, Anglin MD, Hser YI, Anis AH. Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction. 2012 Sep; 107(9):1621-9.
    View in: PubMed
    Score: 0.007
  34. Eby LT, Sparks TE, Evans E, Selzer JA. A qualitative examination of the positive and negative consequences associated with going tobacco-free in substance abuse treatment: the NY State experience. Nicotine Tob Res. 2012 Dec; 14(12):1407-17.
    View in: PubMed
    Score: 0.007
  35. Fosados R, Evans E, Hser YI. Ethnic differences in utilization of drug treatment services and outcomes among Proposition 36 offenders in California. J Subst Abuse Treat. 2007 Dec; 33(4):391-9.
    View in: PubMed
    Score: 0.005
  36. Hser YI, Evans E, Teruya C, Huang D, Anglin MD. Predictors of short-term treatment outcomes among California's Proposition 36 participants. Eval Program Plann. 2007 May; 30(2):187-96.
    View in: PubMed
    Score: 0.005
  37. Hser YI, Teruya C, Brown AH, Huang D, Evans E, Anglin MD. Impact of California's Proposition 36 on the drug treatment system: treatment capacity and displacement. Am J Public Health. 2007 Jan; 97(1):104-9.
    View in: PubMed
    Score: 0.005
  38. Hser YI, Grella C, Evans E, Huang YC. Utilization and outcomes of mental health services among patients in drug treatment. J Addict Dis. 2006; 25(1):73-85.
    View in: PubMed
    Score: 0.005
  39. Hser YI, Evans E, Huang D, Anglin DM. Relationship between drug treatment services, retention, and outcomes. Psychiatr Serv. 2004 Jul; 55(7):767-74.
    View in: PubMed
    Score: 0.004
  40. Hser YI, Teruya C, Evans EA, Longshore D, Grella C, Farabee D. Treating drug-abusing offenders. Initial findings from a five-county study on the impact of California's Proposition 36 on the treatment system and patient outcomes. Eval Rev. 2003 Oct; 27(5):479-505.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.